ProShare Advisors LLC Raises Stock Holdings in Danaher Corporation $DHR

ProShare Advisors LLC raised its position in shares of Danaher Corporation (NYSE:DHR) by 7.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 122,497 shares of the conglomerate’s stock after buying an additional 8,139 shares during the period. ProShare Advisors LLC’s holdings in Danaher were worth $28,042,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. JPL Wealth Management LLC bought a new position in shares of Danaher during the third quarter valued at about $25,000. Elevated Capital Advisors LLC bought a new stake in shares of Danaher in the fourth quarter worth about $26,000. WFA of San Diego LLC purchased a new position in Danaher during the 2nd quarter valued at about $26,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher during the 3rd quarter valued at about $27,000. Finally, Financial Life Planners bought a new position in Danaher during the 3rd quarter valued at approximately $32,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Wells Fargo & Company decreased their target price on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. Evercore raised their price target on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. UBS Group cut their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Finally, TD Cowen decreased their price objective on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average price target of $238.65.

Danaher Stock Up 2.5%

DHR stock opened at $171.19 on Thursday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a market capitalization of $121.16 billion, a price-to-earnings ratio of 33.11, a price-to-earnings-growth ratio of 2.23 and a beta of 0.81. The business’s 50 day moving average price is $184.41 and its two-hundred day moving average price is $209.29. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87.

Danaher (NYSE:DHR) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.88 EPS. As a group, analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s dividend payout ratio is currently 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.